PEP-Therapy
Innovative peptides
as targeted therapies for oncology
LATEST NEWS
June 4th, 2024
We are happy to share updates on our PEP-010 program at the EACR Annual Meeting which will be held June 10-13 in Rotterdam, Netherlands.
Come and visit our posters!
May 30th, 2024
PEP-Therapy appoints Hatem Azim, MD, PhD, as Chief Medical Officer.
+ READ MORE
April 25th, 2024
PEP-Therapy and Institut Curie announce first patients dosed in Phase Ib clinical trial evaluating PEP-010 in ovarian and pancreatic cancers.
+ READ MORE
